AI-generated summary
The authors reviewed trials of agomelatine and melatonin for preventing seasonal affective disorder in adults with a history of the condition. They identified only one eligible randomized trial, of 225 participants comparing agomelatine with placebo, and found no trials of melatonin. The results for SAD incidence and severity were uncertain, and the evidence was rated very low certainty, so the authors could draw no conclusion about efficacy or safety.
- Participants
- 225
- Studies included
- 1
- Who or what was studied
- Adults with a history of winter-type seasonal affective disorder who were free of symptoms at the start of the study
- Limits stated in the abstract
- Only one eligible study was included, nearly half of its participants left before completion, and the certainty of evidence was very low.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Risk of bias, Adverse event, Meta-analysis, Depression, Attrition. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.